Mark G. Foletta, Director at DEXCOM INC (DXCM), sold 5,492 shares at $85.17 ($468K) on 2025-07-15, disclosed to the SEC on 2025-07-17.
Scheduled sale ($468k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.17 | 2,742 | $234K | 49.9% |
| 2 | $85.17 | 2,742 | $234K | 49.9% |
| 3 | $86.03 | 8 | $688 | 0.1% |
| Total | $85.17 avg | 5,492 | $468K | 100% |
| Filing → |
| AMN | SELL | 2026-06-17 | $114K | — | Filing → |
| DXCM | SELL | 2025-08-18 | $430K | — | Filing → |
| DXCM | SELL | 2025-06-18 | $457K | — | Filing → |